Company Ticker News September 23, 2021Verve Therapeutics' Gene-Editing Therapy Shows Encouraging Preclinical Action In Cardiovascular Disease 0 0 Share
Company Ticker News August 12, 2021Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results 0 0 Share